Dr. Karen J. Brunke

Dr. Karen J. Brunke has a diverse work experience in the biotechnology and pharmaceutical industry. Dr. Karen J. is currently the Acting Chief Executive Officer at Magdalena Biosciences, Inc. Prior to that, they served as the Director on the Board of Directors at CytoDyn and as the Executive Vice President of Corporate and Business Development at Jaguar Health. Dr. Brunke also worked as a Business Development Consultant at Jaguar Health and Eleison Pharmaceuticals, as well as an Entrepreneur. Dr. Karen J. has served as a BD Consultant and part-time SVP of BD at Eleison Pharmaceuticals Inc. Dr. Brunke has also worked as an Independent Consultant, where they held the position of Head from 2014 to 2018. Earlier in their career, they were the President & CEO of Cardeus Pharmaceuticals, Inc. and an Advisor at Mitsui & Co. Global Investment Ltd. Dr. Karen J. also worked as an Entrepreneur at Mitsui Global Investment. Dr. Brunke started their career in 2006 as the Head of Pharmaceutical Partnering & Licensing at Pharmaceutical Partnering and Licensing.

Dr. Karen J. Brunke has pursued postdoctoral research at the Institute for Cancer Research. Additionally, they have attended the University of Pennsylvania, though no specific degree or field of study information is available.